Is There a Role for Intensive Insulin Therapy in Patients With Kidney Disease?

American Journal of Kidney Diseases

Volumn 50, Issue 3, 2007, Pages 371-378

  Ritchie McLean, Susanna ^a   Kirwan, Chris ^a   Levy, Jeremy B ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

acute kidney injury; chronic kidney disease; Intensive insulin therapy; kidney failure; sepsis

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADVERSE OUTCOME; ANTIINFLAMMATORY ACTIVITY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COMORBIDITY; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; INSULIN RESISTANCE; INSULIN TREATMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LIPID METABOLISM; PATHOPHYSIOLOGY; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

CHRONIC DISEASE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN; INTENSIVE CARE; KIDNEY DISEASES; KIDNEY FAILURE, ACUTE;

EID: 34548032141     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.05.011     Document Type: Review

References (42)

1. Van den Berghe G., Wilmer A., and Hermans G. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
2. Van den Berghe G., Wouters P., and Weekers F. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
3. Malmberg K. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314 (1997) 1512-1515
4. Krinsley J.S. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79 (2004) 992-1000
5. Goldberg P., Siegel M., Sherwin R., et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care 27 (2004) 461-467
6. Metcalf W., Simpson M., Khan I.H., et al. Scottish Renal Registry: Acute renal failure requiring renal replacement therapy: Incidence and outcome. QMJ 95 (2002) 579-583
7. Liano F., and Pascual J. Madrid Acute Renal Failure Study Group: The spectrum of acute renal failure seen in the intensive care unit compared with that seen in other settings. Kidney Int 50 (1998) 811-818
8. Brivet F.G., Kleinknecht D., Loirat P., and Landais P.J.M. The French Study Group on Acute Renal Failure: Acute renal failure in intensive care units: Causes, outcome and prognostic factors of hospital mortality: A prospective multicenter study. Crit Care Med 24 (1996) 192-198
9. Carpentier Y.A., and Scruel O. Changes in the concentration and composition of plasma lipoproteins during the acute phase response. Curr Opin Clin Nutr Metab Care 5 (2002) 153-158
10. Mesotten D., Swinnen J.V., Vanderhoydonc F., Wouters P.J., and Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89 (2004) 219-226
11. Weekers F., Guiluetti A.P., Michalaki M., et al. Metabolic, endocrine, and immune effects of stress hyperglycaemia in a rabbit model of prolonged critical illness. Endocrinology 144 (2003) 5329-5338
12. Van de Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol 23 (2002) 370-391
13. McCowen K.C., Malhotra A., and Bistrian B.R. Stress-induced hyperglycaemia. Crit Care Clin 17 (2001) 107-124
14. Khani S., and Tayek J.A. Cortisol increases gluconeogenesis in humans: Its role in the metabolic syndrome. Clin Sci 101 (2001) 739-747 (Lond)
15. Grimble R.F. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care 5 (2002) 551-559
16. Petersen K.F., and Shulman G.I. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90 (2002) 11G-18G
17. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J Clin Invest 114 (2004) 1187-1195
18. Gordon B.R., Parker T.S., Levine D.M., et al. Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia. Crit Care Med 24 (1996) 584-589
19. Gui D., Spada P.L., De Gaetano A., and Pacelli F. Hypocholesterolemia and risk of death in the critically ill surgical patient. Intensive Care Med 22 (1996) 790-794
20. Baker E.H., Janaway C.H., Philips B.J., et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 61 (2006) 284-289
21. McAlister F.A., Majumdar S.R., Blitz S., Rowe B.H., Romney J., and Marrie T.J. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28 (2005) 810-815
22. Frontera J., Fernandez A., Claassen J., et al. Hyperglycaemia after SAH: Predictors, associated complications, and impact on outcome. Stroke 37 (2006) 199-203
23. Capes S.E., Hunt D., Malmberg K., Pathak P., and Gerstein H.C. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview. Stroke 32 (2001) 2426-2432
24. Suleiman M., Hammerman H., Boulos M., et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation 111 (2005) 754-760
25. Barsheshet A., Garty M., Grossman E., et al. Admission blood glucose level and mortality among hospitalized non-diabetic patients with heart failure. Arch Intern Med 166 (2006) 1613-1619
26. Rovlias A., and Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 46 (2000) 335-342
27. Desai D., March R., and Watters J.M. Hyperglycemia after trauma increases with age. J Trauma 29 (1989) 719-723
28. Pekala P., Marlow M., Heuvelman D., and Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 265 (1990) 18051-18054
29. Shikhman A.R., Brinson D.C., Valbracht J., and Lotz M.K. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 167 (2001) 7001-7008
30. Quinn L.A., and McCumbee W.D. Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 177 (1998) 94-102
31. Clerici C., and Matthay M.A. Hypoxia regulates gene expression of alveolar epithelial transport proteins. J Appl Physiol 88 (2000) 1890-1896
32. Sanchez-Alvarez R., Tabernero A., and Medina J.M. Endothelin-1 stimulates the translocation and upregulation of both glucose transporter and hexokinase in astrocytes: Relationship with gap junctional communication. J Neurochem 89 (2004) 703-714
33. Rao A.K., Chouhan V., Chen X., et al. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 48 (1999) 1156-1161
34. Black C.T., Hennessey P.J., and Andrassy R.J. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 30 (1990) 830-832
35. Lazar H.L., Chipkin S.R., Fitzgerald C.A., Bao Y., Cabral H., and Apstein C.S. Tight glycemic control in diabetic coronary artery bypass graft patients improves peri-operative outcomes and decreases recurrent ischemic events. Circulation 109 (2004) 1497-1502
36. Mak R.H.K., and DeFronzo R.A. Glucose and insulin metabolism in uraemia. Nephron 61 (1992) 377-382
37. Bagdade J.D., and Albers J.J. Plasma high density lipoprotein concentrations in chronic hemodialysis and renal transplant patients. N Engl J Med 296 (1977) 1436-1439
38. Harris H.W., Grunfeld C., and Feingold K.R. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 91 (1993) 1028-1034
39. Vanhorebeek I., De Vos R., Mesotten D., Wouters P.J., De Wolf-Peeters C., and Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 365 (2005) 53-59
40. Jonassen A., Aasum E., Riemersma R., Mjos O., and Larsen T. Glucose-insulin-potassium reduces infarct size when administered during reperfusion. Cardiovasc Drugs Ther 14 (2000) 615-623
41. Malmberg K., Ryden L., and Efendic S. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): Effects on mortality at one year. J Am Coll Cardiol 26 (1995) 57-65
42. Malmberg K., Efendic S., and Ryden L. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI. Diabetes Care 17 (1994) 1007-1014